Cantor Fitzgerald Reiterates Overweight on Aravive, Maintains $18 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Aravive (NASDAQ:ARAV) and maintained a price target of $18.

July 17, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aravive's stock rating has been reiterated as Overweight by Cantor Fitzgerald, with a maintained price target of $18.
The reiteration of an Overweight rating by a reputable analyst like Louise Chen from Cantor Fitzgerald is a positive signal for Aravive. It suggests that the analyst believes the company's stock will outperform the market, which could lead to an increase in the stock's price in the short term. The maintained price target of $18 also indicates that the analyst believes the stock is currently undervalued.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100